Recent human topical evidence A 2023 IRB-approved 21-woman topical trial of NEEL gel (a stabilized GHK-Cu topical) reported an average 28% increase in skin collagen density at 3 months, with a top quartile reporting 51%
For more detail, see our Retatrutide dosage guide and our comprehensive peptide half-life chart reference
All patients will be adequately informed, both verbally and in writing, of the nature of the trial, its aim, and its risks and possible benefits
Thursdays vote tally reflected the unusual makeup of the panel
The peptide has been characterized in tendon, ligament, muscle, gut, vascular, neural and bone injury models, where it consistently accelerates structural recovery, restores barrier function and rescues vascular perfusion through a coordinated upregulation of growth factor receptors, the nitric oxide system and angiogenic signaling [13]